BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 12952752)

  • 21. [Treatment of erythema nodosum leprosum using thalidomide].
    Sheskin J
    Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
    [No Abstract]   [Full Text] [Related]  

  • 22. Severe form of type 2 reaction in patients of Hansen's disease after withdrawal of thalidomide: case reports.
    Rattan R; Shanker V; Tegta GR; Verma GK
    Indian J Lepr; 2009; 81(4):199-203. PubMed ID: 20704076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The promise of thalidomide: evolving indications.
    Joglekar S; Levin M
    Drugs Today (Barc); 2004 Mar; 40(3):197-204. PubMed ID: 15148528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential novel uses of thalidomide: focus on palliative care.
    Peuckmann V; Fisch M; Bruera E
    Drugs; 2000 Aug; 60(2):273-92. PubMed ID: 10983733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalidomide in erythema nodosum leprosum.
    Jew LJ; Middleton RK
    DICP; 1990 May; 24(5):482-3. PubMed ID: 2188435
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful long-term thalidomide therapy for discoid lupus erythematosus-lichen planus overlap syndrome.
    Zhang L; Au S; Aronson IK
    Dermatol Online J; 2014 Oct; 20(10):. PubMed ID: 25526013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thalidomide for erythema nodosum leprosum and other applications.
    Okafor MC
    Pharmacotherapy; 2003 Apr; 23(4):481-93. PubMed ID: 12680478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pentoxifylline in the treatment of erythema nodosum leprosum.
    De Carsalade GY; Achirafi A; Flageul B
    J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thalidomide and analogues: potential for immunomodulation of inflammatory and neoplastic dermatologic disorders.
    Ladizinski B; Shannon EJ; Sanchez MR; Levis WR
    J Drugs Dermatol; 2010 Jul; 9(7):814-26. PubMed ID: 20677538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dermatologic and nondermatologic uses of thalidomide.
    Nasca MR; Micali G; Cheigh NH; West LE; West DP
    Ann Pharmacother; 2003 Sep; 37(9):1307-20. PubMed ID: 12921515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current therapeutic indications of thalidomide and lenalidomide].
    Ordi-Ros J; Cosiglio FJ
    Med Clin (Barc); 2014 Apr; 142(8):360-4. PubMed ID: 23830554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case report of venous thrombosis in a leprosy patient treated with corticosteroid and thalidomide.
    Vetrichevvel TP; Pise GA; Thappa DM
    Lepr Rev; 2008 Jun; 79(2):193-5. PubMed ID: 18711941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thalidomide: new uses for an old drug].
    Wu KL; Sonneveld P
    Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.
    Costa PDSS; Fraga LR; Kowalski TW; Daxbacher ELR; Schuler-Faccini L; Vianna FSL
    Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Thalidomide in dermatology].
    Hunziker T; Krebs A
    Hautarzt; 1983 Feb; 34(2):66-72. PubMed ID: 6841082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bullous erythema nodosum leprosum. A case report in French Guiana].
    CouppiƩ P; Sainte-Marie D; About V; Heid E; Pradinaud R
    Ann Dermatol Venereol; 1998 Mar; 125(3):188-90. PubMed ID: 9747246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].
    Petering H; Kiehl P; Vogelbruch M; Sticht-Groh V; Kapp A; Werfel T
    Hautarzt; 2001 Oct; 52(10 Pt 2):966-9. PubMed ID: 11715395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses.
    Tseng S; Pak G; Washenik K; Pomeranz MK; Shupack JL
    J Am Acad Dermatol; 1996 Dec; 35(6):969-79. PubMed ID: 8959957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of pentoxifylline, thalidomide and prednisone in the treatment of ENL.
    Moreira AL; Kaplan G; Villahermosa LG; Fajardo TJ; Abalos RM; Cellona RV; Balagon MV; Tan EV; Walsh GP
    Int J Lepr Other Mycobact Dis; 1998 Mar; 66(1):61-5. PubMed ID: 9614845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.